Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial.
Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):108-115.
Více informací ZDE
Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
Radiother Oncol. 2020 Jan;142:52-61.
Více informací ZDE
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer.
Radiother Oncol. 2020 Jan;142:62-71.
Více informací ZDE
Toxicity and Biochemical Outcomes of Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial.
Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):282-290.
Více informací ZDE
Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome.
Radiother Oncol. 2020 Feb;143:24-29.
Více informací ZDE
Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial.
J Clin Oncol. 2020 Feb 20;38(6):593-601.
Více informací ZDE
Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial.
Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):706-714.
Více informací ZDE
Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial.
Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):693-702.
Více informací ZDE
Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study.
Radiother Oncol. 2020 Mar;144:65-71.
Více informací ZDE
Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial.
Radiother Oncol. 2020 Mar;144:209-217.
Více informací ZDE
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
J Clin Oncol. 2020 Mar 1;38(7):706-714.
Více informací ZDE
Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.
Oncologist. 2020 Apr;25(4):e701-e708.
Více informací ZDE
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
J Clin Oncol. 2020 Apr 1;38(10):1019-1029.
Více informací ZDE
Imaging-based Target Volume Reduction in Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer (PET-Plan): A Multicentre, Open-Label, Randomised, Controlled Trial.
Lancet Oncol. 2020 Apr;21(4):581-592.
Více informací ZDE
Late Toxicity and Quality of Life With Prostate Only or Whole Pelvic Radiation Therapy in High Risk Prostate Cancer (POP-RT): A Randomised Trial.
Radiother Oncol. 2020 Apr;145:71-80.
Více informací ZDE
Randomized, Placebo-Controlled Clinical Trial Combining Pentoxifylline-Tocopherol and Clodronate in the Treatment of Radiation-Induced Plexopathy.
Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):154-162.
Více informací ZDE
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.
J Clin Oncol. 2020 May 20;38(15):1685-1692.
Více informací ZDE
Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer.
J Clin Oncol. 2020 May 20;38(15):1676-1684.
Více informací ZDE
Quality of Life After Breast-Conserving Therapy and Adjuvant Radiotherapy for Non-Low-Risk Ductal Carcinoma in Situ (BIG 3-07/TROG 07.01): 2-year Results of a Randomised, Controlled, Phase 3 Trial.
Lancet Oncol. 2020 May;21(5):685-698.
Více informací ZDE
Hypofractionated Breast Radiotherapy for 1 Week Versus 3 Weeks (FAST-Forward): 5-year Efficacy and Late Normal Tissue Effects Results From a Multicentre, Non-Inferiority, Randomised, Phase 3 Trial.
Lancet. 2020 May 23;395(10237):1613-1626.
Více informací ZDE
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.
J Clin Oncol. 2020 Jun 1;38(16):1763-1773.
Více informací ZDE
Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401) †.
Eur Urol. 2020 Jun;77(6):689-698.
Více informací ZDE
Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT).
Eur Urol. 2020 Jun;77(6):713-724.
Více informací ZDE
Compliance and Tolerability of Short-Course Radiotherapy Followed by Preoperative Chemotherapy and Surgery for High-Risk Rectal Cancer - Results of the International Randomized RAPIDO-trial.
Radiother Oncol. 2020 Jun;147:75-83.
Více informací ZDE
Outcomes for Hyperthermia Combined with Concurrent Radiochemotherapy for Patients with Cervical Cancer.
Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):499-511.
Více informací ZDE
No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT Trial.
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):701-709.
Více informací ZDE
Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer.
Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):943-948.
Více informací ZDE
Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.
Radiother Oncol. 2020 Sep;150:18-25.
Více informací ZDE
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.
Lancet Oncol. 2020 Oct;21(10):1331-1340.
Více informací ZDE
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
Lancet Oncol. 2020 Oct;21(10):1341-1352.
Více informací ZDE
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol. 2020 Oct;21(10):1366-1377.
Více informací ZDE
Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trial.
Ann Oncol. 2020 Oct;31(10):1376-1385.
Více informací ZDE
Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700).
Oncology. 2020;98(11):763-770.
Více informací ZDE
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.
J Clin Oncol. 2020 Oct 1;38(28):3261-3272.
Více informací ZDE
Dexamethasone for the Prevention of a Pain Flare After Palliative Radiation Therapy for Painful Bone Metastases: The Multicenter Double-Blind Placebo-Controlled 3-Armed Randomized Dutch DEXA Study.
Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):546-553.
Více informací ZDE
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial.
J Clin Oncol. 2020 Nov 20;38(33):3905-3913.
Více informací ZDE
Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
J Clin Oncol. 2020 Nov 1;38(31):3604-3614.
Více informací ZDE
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
J Clin Oncol. 2020 Nov 1;38(31):3615-3625.
Více informací ZDE
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial.
J Clin Oncol. 2020 Dec 10;38(35):4175-4183.
Více informací ZDE
Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer.
J Clin Oncol. 2020 Dec 1;38(34):4010-4018.
Více informací ZDE
Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
Lancet Oncol. 2020 Dec;21(12):1602-1610.
Více informací ZDE
